CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published ahead of print on June 6, 2007
Clin J Am Soc Nephrol 2: 839-846, 2007
© 2007 American Society of Nephrology
doi: 10.2215/CJN.04101206
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.04101206v1
2/4/839    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLoach, S. S.
Right arrow Articles by Mohler, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeLoach, S. S.
Right arrow Articles by Mohler, E. R., III

Special Feature: Primary Care Issues for the Nephrologists

Peripheral Arterial Disease: A Guide for Nephrologists

Stephanie S. DeLoach*, and Emile R. Mohler, III{dagger}

* Department of Medicine, Renal, Electrolyte and Hypertension Division; and {dagger} Cardiovascular Disease Division, Vascular Medicine Section, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: Dr. Emile R. Mohler, III, Hospital of the University of Pennsylvania, 4th Floor Penn Tower Building 3400 Spruce Street, Philadelphia, PA 19104. Phone: 215-662-3275; Fax: 215-662-3255; mohlere{at}uphs.upenn.edu

Cardiovascular disease is a major source of morbidity and mortality for patients with chronic kidney disease (CKD). Peripheral arterial disease (PAD) is a strong predictor of coronary artery disease and a risk factor for mortality in the general population. This is of particular interest to nephrologists because the risk for PAD is increased in CKD. Often, PAD is overlooked as a source of morbidity and as a cardiovascular risk factor in this population. This review serves as an overview of the epidemiology, screening, diagnosis, and treatment of PAD with an emphasis on CKD.




This article has been cited by other articles:


Home page
 QJMHome page
P.C. Bennett, S. Silverman, P.S. Gill, and G.Y.H. Lip
Ethnicity and peripheral artery disease
QJM, January 1, 2009; 102(1): 3 - 16.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Nephrology.